ABSTRACT
Background and Aims
Bangladesh is experiencing a critical epidemiological shift, with non‐communicable diseases (NCDs) now accounting for nearly 67% of all deaths nationwide. These diseases, including cardiovascular conditions and diabetes, driven by unregulated urban growth, poor dietary habits, and sedentary lifestyles, pose a major threat to public health. This narrative review aims to analytically evaluate the multifaceted drivers of Bangladesh's NCD crisis, critique current policy gaps, and propose evidence‐informed, scalable strategies.
Methods
A comprehensive literature search was conducted using PubMed, Google Scholar, and the Bangladesh Ministry of Health and Family Welfare (MoHFW) archives for data published between 2010 and 2024. Keywords included “non‐communicable diseases,” “Bangladesh,” “health policy,” and “urbanization.” Evidence was synthesized through a narrative approach, utilizing a SWOT analytical framework to identify strategic priorities. This methodology specifically targeted the “implementation gap” by analyzing the discrepancy between written national policy and actual grassroots health delivery.
Results
This review identifies that although initiatives like the National NCD Control Program have laid the groundwork, key challenges remain specifically, underfunding, shortages of specialized healthcare providers, weak data systems, and fragmented governance. Comparative insights from successes such as Sri Lanka's “Healthy Lifestyle Centers” and Thailand's community health worker mobilization suggest that standardized protocols and decentralized care models can be effectively adapted to Bangladesh's socio‐economic context. Furthermore, the commercial determinants of health, specifically the unregulated marketing of ultra‐processed foods, significantly exacerbate risk factors. Analytically, the review finds that “techno‐optimism” surrounding AI must be secondary to foundational primary care reforms.
Conclusion
Bangladesh is recommended to transition from reactive care to a proactive, integrated chronic disease management framework. This necessitates legislative reforms, sustainable financing through health‐related taxation, and digital innovation. Addressing the NCD crisis requires an integrated, whole‐of‐government approach to secure public health resilience.
Keywords: AI in healthcare, Bangladesh health policy, chronic disease prevention, health system reform, non‐communicable diseases (NCDs), public health equity, urban health risks
1. Introduction
Over recent decades, Bangladesh has undergone a marked epidemiological transition, with non‐communicable diseases (NCDs) emerging as the leading cause of morbidity and mortality [1]. Once predominantly burdened by infectious diseases, the country now confronts a surge in chronic conditions such as cardiovascular diseases, diabetes, cancers, and chronic respiratory illnesses [2, 3]. This shift is propelled by accelerated urbanization, lifestyle changes—including poor dietary habits and physical inactivity—and socio‐economic transformations that have redefined health risks across all strata of the population. These trends mirror broader global health patterns, but the speed and scale of change in Bangladesh pose distinct public health challenges [4, 5].
The World Health Organization (WHO) has identified NCDs as a major threat to low‐ and middle‐income countries, where healthcare systems are often underprepared for sustained chronic care delivery [6, 7]. For Bangladesh, this shift carries far‐reaching socio‐economic implications, ranging from escalating healthcare expenditures and productivity loss to worsening health inequities [8].
While existing literature has extensively documented the rising prevalence of NCDs in Bangladesh, many analyses remain limited to epidemiological descriptions or broad policy summaries that lack a critical assessment of implementation feasibility. This review adds a distinctive analytical contribution by moving beyond problem description; it utilizes a structured SWOT framework to examine the intersection of urban governance, the commercial determinants of health, and the logistical sequencing of digital innovations. By providing a prioritized roadmap, distinguishing between immediate workforce needs and long‐term technological aspirations, this article offers a strategic framework for policymakers seeking to bridge the “knowledge‐to‐action” gap in a resource‐constrained setting.
2. Methods
This article is a narrative review informed by a structured search of published literature and selected national policy documents. A comprehensive search was performed on electronic databases, including PubMed, Google Scholar, and the archives of the Ministry of Health and Family Welfare (MoHFW). The search was restricted to English‐language sources published between 2010 and 2024. Selection criteria prioritized peer‐reviewed articles, national demographic surveys (e.g., STEPS 2018), and WHO technical reports. Evidence was synthesized through a thematic approach, categorizing data into epidemiological drivers, systemic gaps, and policy opportunities.
To ensure analytical rigor, the synthesis logic specifically targeted the intersection of clinical outcomes and socio‐economic determinants. The review utilized a SWOT framework to evaluate the readiness of the Bangladeshi health system. This methodology involved benchmarking Bangladesh's policy trajectory against comparable LMICs like Thailand and Sri Lanka, ensuring that the recommendations provided are not merely normative but are grounded in regional evidence of what works in resource‐constrained settings. The expansion of this section reflects the inclusion of specific review criteria for “Commercial Determinants of Health” (CDH) and “Health System Resilience.”
3. Factors Contributing to the Rise of NCDs
3.1. Urbanization, “Food Swamps,” and the Political Economy of Space
Bangladesh's rapid urbanization has significantly altered population behaviors, contributing directly to rising NCD risks. Analytically, the Bangladeshi urban landscape has evolved into a “Food Swamp,” where the physical availability of healthy options is overwhelmed by an overabundance of energy‐dense, ultra‐processed foods. Urban dwellers increasingly adopt sedentary lifestyles and consume foods high in sugar and sodium. These dietary patterns are strongly associated with obesity, hypertension, and dyslipidemia [9, 10, 11, 12].
Furthermore, the lack of health‐sensitive urban planning is an analytical reflection of the “political economy of space.” In major cities, commercial interests often supersede public health needs, leading to the depletion of green zones and pedestrian pathways. This lack of “walkability” is a structural driver of obesity that cannot be solved by individual behavior change alone. To reverse this trajectory, zoning policies that regulate food environments and provide accessible recreational facilities are critical requirements for healthier living. Urban health governance must be integrated into NCD prevention strategies to address these built‐environment risks.
3.2. Socio‐Economic Shifts, Epigenetic Vulnerability, and the Barker Hypothesis
While economic growth has improved life expectancy, it has also exacerbated health disparities [13, 14]. A critical evaluation of this crisis must consider the “Barker Hypothesis,” which suggests that fetal undernutrition leads to increased NCD risk in adulthood [15, 16, 17, 18]. Bangladesh faces a unique “double burden” where maternal malnutrition programs the offspring's metabolism to be “thrifty,” making them highly vulnerable to metabolic syndrome when exposed to modern urban diets. Poorer populations face financial and geographical barriers to accessing healthcare, leading to delayed diagnosis [19].
In effect, NCDs in Bangladesh function as a “poverty trap.” According to the World Bank's 2023 Public Expenditure Review, Bangladesh's out‐of‐pocket (OOP) healthcare expenditure has reached 74% [20], approximately 5 million individuals are pushed into poverty annually due to medical costs [21], and 24.7% of households face catastrophic health expenditure (CHE) [22]. A substantial portion of this expenditure is driven by the long‐term cost of NCD medications, creating a “medical poverty trap” for the bottom two quintiles of the population (see Figure 1) [23, 24, 25]. Strengthening universal health coverage and introducing subsidized management are vital to narrowing these inequities and preventing the cycle of medical impoverishment that currently drains the socio‐economic vitality of the nation.
Figure 1.

The “medical poverty trap”: An analytical nexus of NCD drivers. This nexus delineates the structural cycle of medical impoverishment, where epigenetic vulnerabilities—rooted in fetal undernutrition—intersect with unregulated commercial determinants of health. The resulting high out‐of‐pocket expenditure (74%) functions as a “poverty trap,” annually pushing 5 million individuals into financial instability due to the long‐term costs of chronic management. Analytically, this diagram argues that the NCD crisis is a consequence of “environmental externalities” and regulatory capture, requiring a whole‐of‐government response to protect national GDP and human capital.
3.3. Environmental Externalities and Occupational Vulnerability
Air pollution, largely driven by traffic and unregulated industrial activity, is a major risk factor for chronic respiratory conditions [26]. Simultaneously, workers in informal sectors like shipbreaking and textiles are routinely exposed to carcinogens, increasing their susceptibility to diseases like COPD and cancer [27, 28]. Theoretically, these risks are “environmental externalities”—costs of industrial growth that the private sector shifts onto the public health system. Strengthening environmental protection frameworks and establishing workplace health monitoring are critical requirements for reducing NCD vulnerability and ensuring that economic development does not come at the cost of national health security.
The compounded health and economic burden of NCDs—including premature death and long‐term disability—reduces productivity and GDP growth [29, 30]. Furthermore, public investment in cleaner transport, renewable energy, and safer labor practices can serve dual purposes: improving public health and supporting sustainable development goals.
3.4. Commercial Determinants of Health (CDH) and Regulatory Capture
A critical yet overlooked driver is the influence of the Commercial Determinants of Health. In Bangladesh, the “corporate playbook” of the tobacco and sugar‐sweetened beverage industries involves aggressive marketing targeted at lower‐income and youth demographics, effectively “locking in” unhealthy behaviors early. The industry's use of “Corporate Social Responsibility” (CSR) often serves as a strategic shield against stringent regulation, a phenomenon described as “regulatory capture.”
Strengthening the regulatory framework to counter these commercial influences is essential for long‐term NCD reduction. Policy success depends not just on health education, but on limiting the industry's ability to influence the legislative process and public health narratives. This requires a decoupling of public health policy from private sector financial influence.
3.5. Global Benchmarking and LMIC Comparisons
Experiences from comparable low‐ and middle‐income countries (LMICs) offer instructive insights for Bangladesh. For example, Sri Lanka and Thailand have made notable progress by integrating NCD services into their primary healthcare systems, deploying community health workers, and adopting standard WHO‐PEN protocols [31, 32]. These models demonstrate that even resource‐constrained settings can make measurable gains in NCD control through strategic reforms and capacity‐building.
Bangladesh stands to benefit from regional peer‐learning platforms and South‐South cooperation initiatives. Adopting context‐specific best practices from Thailand's universal coverage model or Sri Lanka's “Healthy Lifestyle Centers” could enhance national preparedness and accelerate progress in managing the epidemic.
4. Statistical Overview: A Macroeconomic and Epidemiological Evaluation
The quantitative landscape of the NCD epidemic in Bangladesh reveals a profound demographic shift that challenges the sustainability of the current health infrastructure. Recent epidemiological data underscore the severity of the crisis, where NCDs now account for approximately 67% of total deaths nationwide [33]. From a cardiovascular perspective, these conditions alone are responsible for 30% of all fatalities, representing the single largest contributor to premature mortality in the country [33, 34]. This trajectory is further complicated by the diabetes epidemic; prevalence reached an alarming 13.9 million cases in 2021 and is projected to escalate to 23.1 million by 2050 [35]. Such a surge implies an impending wave of secondary complications, including chronic kidney disease and retinopathy, which the current system is ill‐equipped to manage.
Economically speaking, these figures represent more than a health crisis; they signify a massive drain on the national GDP. The 2019 Global Burden of Disease Study indicates that NCDs are the leading cause of disability‐adjusted life years (DALYs) lost in Bangladesh, predominantly affecting the working‐age population [36, 37]. According to the Globocan 2022 data, Bangladesh records approximately 167,426 new cancer cases and 116,598 cancer‐related deaths annually. This represents a significant escalation in burden, with esophageal, lip/oral cavity, and lung cancers dominating the male demographic, while breast and cervical cancers remain the leading threats for women [38]. Furthermore, the gender‐specific impact is stark; global trends suggest that while mortality rates associated with the four major NCDs are stagnating globally, they are rising for men and women in several LMICs, with significant gender disparities in outcomes noted for the Bangladeshi population [39].
The financial implications of these statistics necessitate a radical shift in fiscal policy. By 2030, health ministries in countries like Bangladesh will be required to allocate approximately 20% of their budgets to essential NCD interventions to meet Sustainable Development Goal (SDG) target 3.4 [40, 41]. However, a critical evaluation suggests that the “true” burden may be even higher. Current surveillance mechanisms are fragmented, leading to a “surveillance vacuum” where risks in high‐density areas, such as urban slums, remain undetected [42]. For instance, evidence from Dhaka's slums reports a risk factor prevalence of over 95% for inadequate fruit and vegetable intake and 22.7% for overweight or obesity, yet routine screening remains severely limited [43]. Without integrated, real‐time health surveillance and digitized patient registries, Bangladesh risks making policy decisions based on a vast underestimation of the actual disease burden.
5. Public Health Initiatives and Policy Responses
Bangladesh has made initial strides in addressing the growing burden of NCDs, most notably through the establishment of the National NCD Control Program [44]. While the program represents a strategic shift toward decentralized care, a critical evaluation suggests that its success is often hampered by “implementation leakage” where policy intent fails to translate into grassroots service delivery. The initiative focuses on integrating NCD care into primary healthcare settings, specifically through the “NCD Corner” model within Upazila Health Complexes. This approach is intended to facilitate proactive screening and continuous care at the grassroots level, theoretically reducing the overwhelming pressure on tertiary care facilities [45, 46]. However, the functionality of these corners is frequently undermined by a chronic lack of standardized equipment and a dedicated NCD workforce, often leaving them as referral points rather than treatment hubs.
Furthermore, national health education campaigns have been launched to raise awareness of lifestyle risk factors, including tobacco use, poor dietary habits, and physical inactivity [47]. Critically, while these campaigns aim to foster behavioral change, their impact remains uneven due to a “one‐size‐fits‐all” communication strategy that fails to account for the low‐literacy levels and cultural nuances of rural populations. To move beyond descriptive awareness, a transition toward “social marketing” that leverages community influencers is required. To reinforce program design with empirical success, a 2024 quasi‐experimental trial evaluated the WHO‐HEARTS hypertension control package across upazila health complexes in Bangladesh. This study provided a robust evidence base, showing that the intervention group achieved significantly greater blood pressure reduction and hypertension control (62.0% vs. 49.7%) compared to usual care, alongside markedly fewer missed clinic visits (8.8% vs. 39.3%) [48]. These results signify that systemic standardization, rather than just awareness, is the primary driver of clinical success.
International partners, such as the World Health Organization (WHO) and the World Bank, have provided essential technical expertise and funding for pilot models [33, 49]. Yet, an evaluation of the political economy of health in Bangladesh reveals a precarious reliance on this external support. Most health expenditure remains directed toward infectious disease control, leaving chronic care services fundamentally underfunded and unsustainable in the long term [50]. This budgetary bias ignores the reality that NCDs now represent the bulk of the national disease burden. To bridge this gap, Bangladesh should establish a dedicated NCD financing mechanism supported by revenues from tobacco and sugar taxes. Furthermore, institutionalizing long‐term impact requires legislating a National Chronic Disease Act, modeled after successful frameworks adopted in Brazil and Mexico [51, 52]. This act should ensure mandatory NCD screening at the primary care level, minimum training standards for providers, and sustainable financing streams via public health taxes.
6. A Strategic Framework for Health System Transformation and Policy Priorities
The national response to the NCD epidemic has entered a critical juncture. To move beyond descriptive mapping, this framework evaluates the strategic readiness of Bangladesh's health system. The following insights were developed through an evaluative triangulation of the “Multisectoral Action Plan for NCDs (2018–2025),” WHO technical reports, and independent critiques of the grassroots health delivery model. This framework identifies how current systemic capacities can be leveraged against external pressures while addressing internal vulnerabilities (see Figure 2).
Figure 2.

The five‐pillar strategic framework for NCD resilience. This framework illustrates the logistical sequencing of reforms required to bridge Bangladesh's “implementation gap,” prioritizing a stabilized medicine supply chain and workforce mobilization over premature high‐cost digital adoption. By centering the National Chronic Disease Act as a legislative anchor, the model transitions NCD management from a siloed health service to a mandated inter‐ministerial priority. Ultimately, the framework demonstrates that sustainable health system resilience is achieved through fiscal innovations, such as “sin taxes,” which decouple public health funding from precarious external donor reliance.
6.1. Leveraging the Primary Care Network for Scalability
Bangladesh possesses a robust and highly decentralized primary healthcare infrastructure, notably its network of community clinics. The integration of NCD care into this framework represents a significant structural advantage [44, 46]. Evaluation of standardized clinical protocols, such as the WHO‐HEARTS package [48], confirms that hypertension control rates can rise significantly when the existing footprint is utilized effectively. The strategic priority must be to transform these facilities from referral points into centers of continuous, proactive management.
6.2. Resolving “Implementation Leakage” and Resource Constraints
A primary internal barrier is “implementation leakage” the disconnect between centralized policy and actual healthcare delivery. Despite established protocols, NCDs receive less than 5% of the total health budget, leading to systemic weaknesses such as frequent medicine stock‐outs [50]. Furthermore, the scarcity of a specialized workforce in rural regions, combined with fragmented data systems, prevents longitudinal tracking of chronic patients. Resolving these resource constraints is a prerequisite for moving from disconnected screenings to a comprehensive continuum of care.
6.3. Fiscal Innovation and Digital Sovereignty With Strategic AI Opportunity
The current policy environment presents unique opportunities for fiscal reform. Implementing “sin taxes” on tobacco and sugar‐sweetened beverages represents a “dual‐win”: reducing consumption of harmful products while creating a dedicated, sustainable funding stream for NCD services. On the digital front, expanding Electronic Health Records (EHR) offers the opportunity to resolve data fragmentation [42]. South‐South cooperation with countries like Thailand offers a benchmark for achieving health system resilience through strategic purchasing and community‐driven health worker mobilization [32].
Beyond Electronic Health Records (EHR), there is a strategic opportunity to deploy Artificial Intelligence (AI) to bridge the specialist gap. AI‐based clinical decision support systems can assist non‐specialists in cardiovascular risk stratification and early cancer detection, which is particularly vital in rural clinics with limited access to specialists [53, 54]. Evidence suggests that AI and digital tools can significantly expand health coverage in LMICs by automating routine diagnostic tasks, allowing the limited human workforce to focus on complex clinical management [55].
6.4. Mitigating Commercial Determinants and Climate Risks
The most potent external threat remains the influence of the Commercial Determinants of Health (CDH), particularly industry interference that undermines legislative efforts in tobacco and nutrition control. Additionally, rising environmental risks, compounded by climate change, exacerbate respiratory and cardiovascular vulnerability [26]. Premature mortality from NCDs jeopardizes Bangladesh's commitment to achieving SDG target 3.4. Without decisive policy intervention, these external pressures will overwhelm the health system's capacity, stalling national economic growth.
6.5. Institutionalizing Reform: The National Chronic Disease Act
To finalize these strategic priorities, Bangladesh should prioritize enacting a National Chronic Disease Act, modeled after successful frameworks in comparable LMICs [51, 52]. Such legislation would serve as the “legal anchor” needed to mandate NCD screening at the primary care level, establish minimum training standards, and legally protect dedicated funding streams derived from public health taxes. Moving from a policy “plan” to a legislative “mandate” is the most effective way to bridge the implementation gap and ensure that NCD management is permanently embedded in the national health architecture.
7. Challenges and the Way Forward: A Strategic Synthesis
Despite notable advancements, Bangladesh continues to face significant barriers. Evaluative evidence suggests that the “knowledge‐to‐action” gap is rooted in institutional inertia and the historical bias toward infectious disease control. Among the most pressing challenges is the inadequate financial allocation for NCD prevention, which often accounts for less than 5% of the total health budget [50]. Chronic care remains insufficiently prioritized, a funding gap that hinders the scalability of existing programs and limits the introduction of community‐based interventions. Furthermore, there is a critical shortage of trained health personnel capable of delivering comprehensive NCD screening and counseling, particularly in rural and peri‐urban areas [50]. Compounding these issues is the lack of an integrated health information system. Data on NCD prevalence and treatment outcomes are often outdated or fragmented, impeding timely decision‐making and strategic planning [42]. From a policy standpoint, introducing electronic health records (EHR) tailored to chronic diseases is not merely a technological upgrade but a clinical necessity to ensure patient follow‐up and longitudinal care coordination.
Recent evidence from urban slums in Dhaka illustrates the scale of undetected risk, highlighting a profound disconnect between community‐level morbidity and institutional health responses. A 2017 study reported high NCD risk factor prevalence, over 95% for inadequate fruit and vegetable intake and 22.7% for obesity, yet routine screening and early diagnosis remain severely limited [43]. This persistent lack of early detection in high‐density urban populations underscores the failure of traditional, paper‐based outreach; therefore, bridging this divide necessitates a transition toward integrated, real‐time digital health surveillance. However, the move toward “techno‐optimism”, the belief that technology alone can solve systemic failures, must be avoided. Strategically, digital innovations and public‐private partnerships hold promise, but they must be sequenced logically to ensure maximum impact.
In this hierarchy of needs, the medicine supply chain must be the absolute priority. Deploying AI for diagnosis in a system that lacks the basic drugs to treat the patient (e.g., Metformin or Amlodipine) is a misallocation of resources. AI‐enabled decision support systems should be introduced only after foundational infrastructure, such as electricity, data privacy laws, and routine registries, is stabilized. AI must serve as a support tool for the non‐specialist workforce, empowering them to deliver quality care in resource‐constrained settings [53].
To reverse the current trajectory, the government must demonstrate strong political commitment to institutionalize health system reforms focused on chronic disease resilience. This transformation is both urgent and feasible, contingent on aligning urban development strategies with public health goals. Prioritizing walkable environments, regulating polluting industries, and promoting access to affordable, nutritious food require robust inter‐ministerial collaboration. Ensuring that NCD prevention is embedded in broader policies related to housing, agriculture, and transport is the only sustainable way to meet Sustainable Development Goal (SDG) target 3.4.
8. Conclusion
The escalating NCD crisis in Bangladesh is a structural consequence of rapid urbanization, regulatory gaps in the commercial determinants of health, and a health system traditionally optimized for infectious disease control rather than longitudinal care. This review indicates that the implementation gap is the primary barrier to progress; while policies such as the Multisectoral Action Plan are theoretically sound, they are undermined by a persistent siloed approach across ministries and a lack of dedicated, sustainable funding. To institutionalize lasting reform, Bangladesh should now prioritize enacting a National Chronic Disease Act. Such legislation would serve as the legal anchor needed to mandate inter‐ministerial cooperation and create a protected financing stream through health‐related taxation, specifically targeting tobacco and sugar‐sweetened beverages to reduce the 67% mortality burden.
Strategically, the transition toward a resilient health system must be sequenced to favor foundational primary care over the premature adoption of high‐cost digital technologies. While AI‐enabled diagnostics and digitized registries offer transformative potential, their ethical and logistical success is contingent upon a stabilized supply chain for essential medicines and a well‐compensated, non‐specialist workforce. By leveraging the existing decentralized network of Community Clinics and institutionalizing the standardized protocols of the HEARTS package, Bangladesh can mitigate the double burden of malnutrition and chronic illness. Ultimately, a whole‐of‐government approach that treats NCD prevention as an economic necessity rather than a peripheral health issue is required to secure national productivity and ensure healthier, longer lives for future generations.
Author Contributions
Abdullaha Al Mamun: conceptualization, writing – original draft, writing – review and editing, software, visualization, resources, data curation, and validation. The author read, reviewed, and approved the final manuscript. Abdullaha Al Mamun, the corresponding author, had full access to all of the data in this study and takes complete responsibility for the accuracy of the data analysis.
Funding
This research received no specific funding from any funding agency in the public, commercial, or not‐for‐profit sectors. The supporting institutions had no role in study design; collection, analysis, or interpretation of data; writing of the report; or the decision to submit for publication.
Ethics Statement
The author has nothing to report.
Conflicts of Interest
The author declares no conflicts of interest.
Transparency Statement
The lead author, Abdullaha Al Mamun, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
Acknowledgments
The authors express their sincere gratitude to the anonymous reviewers for their invaluable insights and constructive feedback. Their diligent review significantly enhanced the quality and clarity of this manuscript, contributing greatly to its publishable form.
Data Availability Statement
All data relevant to the findings are included within the manuscript. No external data sets were used or generated.
References
- 1. Olufunke Omotayo O., Chinedu Paschal Maduka M., Muridzo Muonde M., Tolulope O Olorunsogo O., and Jane Osareme Ogugua O., “The Rise of Non‐Communicable Diseases: A Global Health Review of Challenges and Prevention Strategies,” International Medical Science Research Journal 4 (2024): 74–88, 10.51594/imsrj.v4i1.738. [DOI] [Google Scholar]
- 2. Al‐Shoaibi A. A. A., Matsuyama A., Khalequzzaman M., et al., “Perceptions and Behavior Related to Noncommunicable Diseases Among Slum Dwellers in a Rapidly Urbanizing City, Dhaka, Bangladesh: A Qualitative Study,” Nagoya Journal of Medical Science 80 (2018): 559–569, 10.18999/nagjms.80.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Noor R. and Munna M. S., “Emerging Diseases in Bangladesh: Current Microbiological Research Perspective,” Tzu Chi Medical Journal 27 (2015): 49–53, 10.1016/j.tcmj.2015.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Riaz B. K., Islam M. Z., Islam A. N. M. S., et al., “Risk Factors for Non‐Communicable Diseases in Bangladesh: Findings of the Population‐Based Cross‐Sectional National Survey 2018,” BMJ Open 10 (2020): e041334, 10.1136/bmjopen-2020-041334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Ahmed S. M., “Non‐Communicable Diseases: Current Scenario and Future Directions (2016),” Bangladesh Health Watch Rep BHWR, accessed May 16, 2025, https://bangladeshhealthwatch.org/reports/bhw-reports.
- 6.World Health Organization, “Noncommunicable Diseases,” accessed May 16, 2025, https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
- 7. Thakur J., Prinja S., Garg C., Mendis S., and Menabde N., “Social and Economic Implications of Noncommunicable Diseases in India,” Indian Journal of Community Medicine 36 (2011): 13, 10.4103/0970-0218.94704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Sultana M., Mahumud R. A., and Sarker A. R., “Burden of Chronic Illness and Associated Disabilities in Bangladesh: Evidence From the Household Income and Expenditure Survey,” Chronic Diseases and Translational Medicine 3 (2017): 112–122, 10.1016/j.cdtm.2017.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Colozza D., Wang Y.‐C., and Avendano M., “Does Urbanisation Lead to Unhealthy Diets? Longitudinal Evidence From Indonesia,” Health & Place 83 (2023): 103091, 10.1016/j.healthplace.2023.103091. [DOI] [PubMed] [Google Scholar]
- 10. Nurwanti E., Hadi H., Chang J.‐S., et al., “Rural–Urban Differences in Dietary Behavior and Obesity: Results of the Riskesdas Study in 10–18‐Year‐Old Indonesian Children and Adolescents,” Nutrients 11 (2019): 2813, 10.3390/nu11112813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Al‐Jawaldeh A. and Abbass M. M. S., “Unhealthy Dietary Habits and Obesity: The Major Risk Factors Beyond Non‐Communicable Diseases in the Eastern Mediterranean Region,” Frontiers in Nutrition 9 (2022): 817808, 10.3389/fnut.2022.817808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Ejigu B. A. and Tiruneh F. N., “The Link Between Overweight/Obesity and Noncommunicable Diseases in Ethiopia: Evidences From Nationwide WHO STEPS Survey 2015,” International Journal of Hypertension 2023 (2023): 1–11, 10.1155/2023/2199853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Aninditya F., Samosir O. B., Susanti H., and Ekananda M., “The Burden of Disease and Economic Growth: The Nonlinear Effect of Population Age Structure,” Heliyon 10 (2024): e30119, 10.1016/j.heliyon.2024.e30119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Jarzebski M. P., Elmqvist T., Gasparatos A., et al., “Ageing and Population Shrinking: Implications for Sustainability in the Urban Century,” npj Urban Sustainability 1 (2021): 17, 10.1038/s42949-021-00023-z. [DOI] [Google Scholar]
- 15. Barker D. J. P., Osmond C., Winter P. D., Margetts B., and Simmonds S. J., “Weight in Infancy and Death From Ischaemic Heart Disease,” Lancet 334 (1989): 577–580, 10.1016/S0140-6736(89)90710-1. [DOI] [PubMed] [Google Scholar]
- 16. Barker D. J. P., Osmond C., Kajantie E., and Eriksson J. G., “Growth and Chronic Disease: Findings in the Helsinki Birth Cohort,” Annals of Human Biology 36 (2009): 445–458, 10.1080/03014460902980295. [DOI] [PubMed] [Google Scholar]
- 17. Hoy W. E. and Nicol J. L., “The Barker Hypothesis Confirmed: Association of Low Birth Weight With All‐Cause Natural Deaths in Young Adult Life in a Remote Australian Aboriginal Community,” Journal of Developmental Origins of Health and Disease 10 (2019): 55–62, 10.1017/S2040174417000903. [DOI] [PubMed] [Google Scholar]
- 18. Lackland D. T., Bendall H. E., Osmond C., Egan B. M., and Barker D. J. P., “Low Birth Weights Contribute to the High Rates of Early‐Onset Chronic Renal Failure in the Southeastern United States,” Archives of Internal Medicine 160 (2000): 1472, 10.1001/archinte.160.10.1472. [DOI] [PubMed] [Google Scholar]
- 19. Rahman M. A., “Socioeconomic Inequalities in the Risk Factors of Noncommunicable Diseases (Hypertension and Diabetes) Among Bangladeshi Population: Evidence Based on Population Level Data Analysis,” PLoS One 17 (2022): e0274978, 10.1371/journal.pone.0274978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.World Bank Group, “World Development Indicators | DataBank,” accessed April 6, 2026, https://databank.worldbank.org/source/world-development-indicators.
- 21. Perry H. B. and Chowdhury A. M. R., “Bangladesh: 50 Years of Advances in Health and Challenges Ahead,” Global Health: Science and Practice 12 (2024): e2300419, 10.9745/GHSP-D-23-00419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Rahman T., Gasbarro D., Alam K., and Alam K., “Rural–Urban Disparities in Household Catastrophic Health Expenditure in Bangladesh: A Multivariate Decomposition Analysis,” International Journal for Equity in Health 23 (2024): 43, 10.1186/s12939-024-02125-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Bhattacharya S., Heidler P., and Varshney S., “Incorporating Neglected Non‐Communicable Diseases Into the National Health Program—A Review,” Frontiers in Public Health 10 (2023): 1093170, 10.3389/fpubh.2022.1093170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ipinnimo T. M., Elegbede O. E., Durowade K. A., et al., “Cost of Illness of Non‐Communicable Diseases in Private and Public Health Facilities in Nigeria: A Qualitative and Quantitative Approach,” Pan African Medical Journal 44 (2023): 6, 10.11604/pamj.2023.44.6.35494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Leng A., Jing J., Nicholas S., and Wang J., “Catastrophic Health Expenditure of Cancer Patients at the End‐Of‐Life: A Retrospective Observational Study in China,” BMC Palliative Care 18 (2019): 43, 10.1186/s12904-019-0426-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Jiang X.‐Q., Mei X.‐D., and Feng D., “Air Pollution and Chronic Airway Diseases: What Should People Know and Do?,” Journal of Thoracic Disease 8 (2016): E31–E40, 10.3978/j.issn.2072-1439.2015.11.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Mishra J., Acharya S., Taksande A. B., Prasad R., Munjewar P. K., and Wanjari M. B., “Occupational Risks and Chronic Obstructive Pulmonary Disease in the Indian Subcontinent: A Critical Review,” Cureus 15, no. 6 (2023): e41149, 10.7759/cureus.41149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Ahamad A. F., Schneider P., Khanum R., Mozumder M. M. H., Mitu S. J., and Shamsuzzaman M. M., “Livelihood Assessment and Occupational Health Hazard of the Ship‐Breaking Industry Workers at Chattogram, Bangladesh,” Journal of Marine Science and Engineering 9 (2021): 718, 10.3390/jmse9070718. [DOI] [Google Scholar]
- 29.“Economics of NCDs—PAHO/WHO,” Pan American Health Organization, published 2024, https://www.paho.org/en/topics/economics-ncds.
- 30. Megari K., “Quality of Life in Chronic Disease Patients,” Health Psychology Research 1 (2013): 27, 10.4081/hpr.2013.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Nair D., Thekkur P., Fernando M., et al., “Outcomes and Challenges in Noncommunicable Disease Care Provision in Health Facilities Supported by Primary Health Care System Strengthening Project in Sri Lanka: A Mixed‐Methods Study,” Healthcare 11 (2023): 202, 10.3390/healthcare11020202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Tuangratananon T., Julchoo S., Phaiyarom M., et al., “Healthcare Providers' Perspectives on Integrating NCDS Into Primary Healthcare in Thailand: A Mixed Method Study,” Health Research Policy and Systems 19 (2021): 139, 10.1186/s12961-021-00791-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.World Health Organization, “Bangladesh Adopts Multisectoral Action Plan for Noncommunicable Disease Control and Prevention,” published 2020, https://www.who.int/bangladesh/news/detail/05-02-2019-bangladesh-adopts-multisectoral-action-plan-for-noncommunicable-disease-control-and-prevention.
- 34.European Union Agency for Asylum. Bangladesh: Cardiology: February 2024. LU: Publications office, 2024.
- 35.International Diabetes Federation, “Bangladesh, Diabetes Country Report 2000–2050. Diabetes Atlas,” accessed May 16, 2025, https://diabetesatlas.org/data-by-location/country/bangladesh/.
- 36.World Health Organization (WHO), “Global Health Estimates: Leading Causes of DALYs,” accessed June 25, 2024, https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys.
- 37. Wen H., Xie C., Wang F., Wu Y., and Yu C., “Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017,” Frontiers in Public Health 8 (2020): 237, 10.3389/fpubh.2020.00237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Sung H., Ferlay J., Siegel R. L., et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71 (2021): 209–249, 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 39. Bennett J. E., Stevens G. A., Mathers C. D., et al., “NCD Countdown 2030: Worldwide Trends in Non‐Communicable Disease Mortality and Progress Towards Sustainable Development Goal Target 3.4,” Lancet 392 (2018): 1072–1088, 10.1016/s0140-6736(18)31992-5. [DOI] [PubMed] [Google Scholar]
- 40. Watkins D. A., Msemburi W. T., Pickersgill S. J., et al., “NCD Countdown 2030: Efficient Pathways and Strategic Investments to Accelerate Progress Towards the Sustainable Development Goal Target 3.4 in Low‐Income and Middle‐Income Countries,” Lancet 399 (2022): 1266–1278, 10.1016/s0140-6736(21)02347-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.NCD Alliance. Financing NCDs. NCD Alliance 2015, accessed May 17, 2025, https://ncdalliance.org/why-ncds/financing-ncds.
- 42. Greco A., “How Data Informs Effective Resource Allocation in Healthcare,” CENTEGIX, published 2022, https://www.centegix.com/blog/how-data-informs-effective-resource-allocation-in-healthcare/.
- 43. Rawal L. B., Biswas T., Khandker N. N., et al., “Non‐Communicable Disease (NCD) Risk Factors and Diabetes Among Adults Living in Slum Areas of Dhaka, Bangladesh,” PLoS One 12 (2017): e0184967, 10.1371/journal.pone.0184967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Biswas T., Pervin S., Tanim M. I. A., Niessen L., and Islam A., “Bangladesh Policy on Prevention and Control of Non‐Communicable Diseases: A Policy Analysis,” BMC Public Health 17 (2017): 582, 10.1186/s12889-017-4494-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Budreviciute A., Damiati S., Sabir D. K., et al., “Management and Prevention Strategies for Non‐Communicable Diseases (NCDS) and Their Risk Factors,” Frontiers in Public Health 8 (2020): 574111, 10.3389/fpubh.2020.574111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Islam K., Huque R., Saif‐Ur‐Rahman K. M., Ehtesham Kabir A. N. M., and Enayet Hussain A. H. M., “Implementation Status of Non‐Communicable Disease Control Program at Primary Health Care Level in Bangladesh: Findings From a Qualitative Research,” Public Health in Practice 3 (2022): 100271, 10.1016/j.puhip.2022.100271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Legesse E., Nigussie T., Girma D., et al., “Level of Adequate Knowledge of Non‐Communicable Diseases and Associated Factors Among Adult Residents of North Shewa Zone, Oromia Region, Ethiopia: A Mixed‐Method Approach,” Frontiers in Public Health 10 (2022): 892108, 10.3389/fpubh.2022.892108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Abrar A., Hu X., Akhtar J., et al., “Evaluation of the World Health Organization‐HEARTS Hypertension Control Package in Bangladesh: A Quasi‐Experimental Trial,” Heart 110 (2024): 1090–1098, 10.1136/heartjnl-2024-324253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.World Bank Blogs, “Bangladesh: Tackling Noncommunicable Diseases Can't Wait,” accessed June 25, 2024, https://blogs.worldbank.org/en/health/bangladesh-tackling-noncommunicable-diseases-can-t-wait.
- 50. Kabir A., Karim M. N., and Billah B., “Health System Challenges and Opportunities in Organizing Non‐Communicable Diseases Services Delivery at Primary Healthcare Level in Bangladesh: A Qualitative Study,” Frontiers in Public Health 10 (2022): 1015245, 10.3389/fpubh.2022.1015245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Aceves B., Ingram M., Nieto C., de Zapien J. G., and Rosales C., “Non‐Communicable Disease Prevention in Mexico: Policies, Programs and Regulations,” Health Promotion International 35 (2020): 409–421, 10.1093/heapro/daz029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Carvalho Malta D., Porto Oliveira T., Aline Siqueira Santos M., Suely Caribé de Araújo Andrade S., and Maria Alves da Silva M., Grupo Técnico de Monitoramento do Plano de DCNT , “Avanços Do Plano De Ações Estratégicas Para O Enfrentamento Das Doenças Crônicas Não Transmissíveis No Brasil, 2011–2015,” Epidemiologia e Serviços de Saúde 25 (2016): 1–2, 10.5123/S1679-49742016000200016. [DOI] [PubMed] [Google Scholar]
- 53. Bozyel S., “Artificial Intelligence‐Based Clinical Decision Support Systems in Cardiovascular Diseases,” Anatolian Journal of Cardiology 28 (2024): 74–86, 10.14744/AnatolJCardiol.2023.3685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Brey Z., Gitau S., Miles M., and Bitton A., “Equity by Design in Artificial Intelligence for Primary Care in Low‐Income and Middle‐Income Countries,” Lancet Primary Care 2 (2026): 100135, 10.1016/j.lanprc.2026.100135. [DOI] [Google Scholar]
- 55. Schwalbe N. and Wahl B., “Artificial Intelligence and the Future of Global Health,” Lancet 395 (2020): 1579–1586, 10.1016/S0140-6736(20)30226-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data relevant to the findings are included within the manuscript. No external data sets were used or generated.
